APOE and Alzheimer disease: The APOE4/4 genotype is the main genetic risk for late onset Alzheimer’s disease (AD), and is associated with a 30–55% risk of developing mild cognitive impairment or AD by age 85, compared to 10–15% for the APOE3/3 genotype.